Table 1.
Patient characteristics.
| Baseline Characteristics | ||
|---|---|---|
| CF (n = 36) | Asthma (n = 81) | |
| Age (y), mean (SD) | 9.4 (2.8) | 9.6 (3.0) |
| Male sex, n (%) | 22 (61) | 43 (53) |
| FEV1 (L), mean (SD) | 1.70 (0.53) | 1.91 (0.76) |
| FEV1%pred, mean (SD) | 87.3 (17.0) | 97.0 (14.3) |
| FVC%pred, mean (SD) | 91.9 (16.3) | 98.5 (11.6) |
| FEV1/FVC, mean (SD) | 0.81 (0.09) | 0.84 (0.08) |
| Homozygous dF508, n (%) | 25 (69) | n.a. |
| Pseudomonas colonisation, n (%) | 12 (33) | n.a. |
| BMI, median (IQR) | 16.6 (16.0–17.6) | n.a. |
| Prophylactic antibiotics, n (%) | 22 (61) | n.a. |
| ICS use, n (%) | 11 (31) | 75 (93) |
| ICS + LABA use, n (%) | n.a. | 33 (41) |
| Atopic, n (%) | n.a. | 62 (76) |
CF: cystic fibrosis; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; ICS: inhaled corticosteroids; BMI: body mass index; LABA: long acting beta agonists; n.a.: not available.